Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRESENT: Compression Therapy vs Antibiotics for Recurrent Erysipelas
NCT07549594Phase 4Not yet recruiting
- Sponsor
- University Hospital Tours
- Start
- Apr 2026
- Primary completion
- Apr 2030
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in erysipelas (2 arms), sponsored by University Hospital Tours. Primary endpoint: Proportion of patients with at least one recurrence of erysipelas during the 1-year prophylaxis phase. Planned start Apr 2026; status: not yet recruiting.
02
Conditions
erysipelas
Beyond the preview
Go deeper on NCT07549594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07549594.